You are here

News


Center for Integration of Science and Industry Receives $2.3M in Funding
Bentley’s Center for Integration of Science and Industry (CISI), founded in 2013 with a $1.3M grant from the National Biomedical Research Foundation (NBRF), was awarded renewed funding from the NBRF: $2.3M over the next five years [...]


Fred Ledley on Bloomberg Radio:  FDA Approves Genetically Modified Salmon (Audio)
Listen in on Dr. Fred Ledley, director of Bentley University's Center for Integration of Science and Industry (CISI), and Aaron Kennon, Co-Founder and Chief Executive Officer of Clear Harbor Asset Management and board member of the Atlantic Salmon Federation, discuss FDA's approval of genetically modified salmon. 


FDA Approves Genetically Modified Salmon
The genetically engineered fish, named the AquAdvantage salmon, is produced by AquaBounty, a Maynard biotechnology company based in Massachusettes. With the FDA's OK, AquaBounty can now offer its modified salmon to American consumers.


Why a Business University and Its Students Should Be Invested in Healthcare Reform
The challenges facing our national healthcare system are undoubtedly among the most pressing concerns of our nation. With an aging population, healthcare costs escalating, and patient need increasing, we must look more than ever to innovative solutions. So what can a university do to prepare tomorrow’s future business leaders to help reform the healthcare system? [...]


ViewPoint: Drug pricing is about worth, not the cost
High drug prices are a target for politicians. In Massachusetts, proposed legislation would limit drug prices and require drug companies to divulge research, marketing and production costs [...]


Bentley University Study Suggests Alzheimer’s Research is Ready to Provide Cures
It has been more than a decade since a new drug was approved for the nearly 5 million Americans suffering from Alzheimer’s disease. Research from the Center for Integration of Science and Industry at Bentley University offers a hopeful view of the prospects for new Alzheimer’s drugs [...]


Fred Ledley on Bloomberg Radio: Do stock buybacks compete with corporate R&D? (Audio)
Listen in on Dr. Fred Ledley, director of Bentley University's Center for Integration of Science and Industry (CISI), offer insight on how biotechnology companies are increasingly at odds with activist investors.


Algal Biofuel Production for Fuel and Feed in a 100-ha Facility
A comprehensive techno-economic analysis and life cycle assessment based on actual production by the Cornell Marine Algal Biofuels Consortium with biomass productivity > 23 g/m2-day.


Nurturing the fruits of scientific discovery
Fred Ledley, opinion leader in the integration of science, business and education, discusses why business models matter in innovation and how societal impact can be enhanced by more efficiently aligning science and industry.


AAAS 2015 Annual Meeting Session - The Business of Innovation: Great Science Is Only the First Step
Fred Ledley discusses the business of innovation with Karen Bernstein, Co-Founder and Chairman of BioCentury, and Gail Naughton, CEO and Chairman of the Board of Histogen Inc.


Post-Doctoral Fellow Appointed to Research Treatment for Neurodegenerative Diseases
Expanding its research on how to accelerate the translation of scientific discoveries into new medicines, the Center for Integration of Science and Industry at Bentley University has appointed Jennifer Beierlein as a post-doctoral fellow.  Beierlein will focus on strategies and policies that may lead to new treatments for neurodegenerative diseases including Alzheimer’s, Dementia and Parkinson’s disease [...]


Fred Ledley: Testifies to Congressional Committee on Energy and Commerce
Dr. Fred Ledley's testimony focuses on business incentives that encourage the development of the highly innovative medicines that are being enabled by the rapid advance of science, including some of the work being done at the Center for Integration of Science and Industry at Bentley University. 


Fred Ledley on Bloomberg's Taking Stock Radio Program: Comments on 21st Century Cures Act (Audio)
Listen in on Fred Ledley, director of Bentley University's Center for Integration of Science and Industry (CISI), and Sam Fazeli, director of research and senior pharmaceutical analyst for Bloomberg Industries, discuss advances in the health care industry geared towards getting drugs to patients more quickly.


Bentley Professor Advocates Incentives to Leverage 21st-Century Science for Innovative Medical Cures
As the U.S. Congress embarks on a first-of-its-kind initiative to help accelerate the pace of medical cures in America, Bentley professor Fred Ledley joined a panel of experts who testified at a congressional hearing in Washington, DC, on incentives for pharmaceutical and device development [...]


Fred Ledley on Bloomberg Radio: 2013 - A remarkable year for biotech (Audio)


Fred D. Ledley Named Fellow, American Association for the Advancement of Science
Fred D. Ledley, Professor of Natural & Applied Sciences and Management, and Director of the Center for Integration of Science and Industry, was named a fellow of the American Association for the Advancement of Science (AAAS). He will be recognized at the AAAS Annual Meeting in Chicago in February 2014 [...]


Post-doctoral Appointment Expand Focus of Center to Sustainable Energy Production
In order to expand its focus to areas of public health and sustainability, the Center for Integration of Science and Industry at Bentley University has appointed two post-doctoral fellows, Andrea Ballabeni, PhD and Michael J. Walsh, PhD [...]


Fred Ledley on Bloomberg Radio: GDP Shift to Foster Innovation (Audio)


Researching Biotech Business Models
Bentley University is the recipient of a $1.3 million grant from the Boston-based National Biomedial Research Foundation, which is to be allocated to the newly created Center for Integration of Science and Industry (CISI) to fund research on biotech business models.


Improving the Business of Science
The Center for Integration of Science and Industry (CISI) at Bentley University solicites a $1.3 million grant from the National Biomedical Research Foundation to fund its efforts in exploring how to translate great science into public value and help make a difference in the world.


Bentley Receives $1.3M to Advance the Integration of Science and Business
The National Biomedical Research Foundation has awarded a $1.3M grant to Bentley University to establish a Center for Integration of Science and Industry, under the direction of Dr. Fred Ledley, Professor of Natural & Applied Sciences and Management [...]


Taking Business Education Into the Future
Professor Fred Ledley of Bentley University talks with editor Jane Schmidt-Wilk about his paper, co-authored by Stephen Holt of Olin College, which argues that business programs should require science courses designed expressly to meet the needs of business students.


Patterns of technological innovation in biotech
Theories of innovation posit that effective product development and value creation require business models and strategies matched to the stage of technology evolution. Such theories are predicated on patterns of technology evolution observed in other fields, where periods of exponential advancement are followed by limits and obsolescence as new technologies emerge [...]


Bridging the boundary between science and business
Concern about the adequacy of America’s scientific and technical workforce for an innovation-driven economy has led to a redoubling of efforts to graduate more students from postsecondary STEM programs. Less attention has focused on the role of STEM education for business professionals who are essential partners in generating economic value from scientific and technical advances [...]